Literature DB >> 21771723

Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk.

Mala Pande1, Margaret R Spitz, Xifeng Wu, Ivan P Gorlov, Wei V Chen, Christopher I Amos.   

Abstract

Chromosome 5p15.33 has been identified by genome-wide association studies as one of the regions that associate with lung cancer risk. A few single-nucleotide polymorphisms (SNPs) in the telomerase reverse transcriptase (TERT) and cleft lip and palate transmembrane 1-like (CLPTM1L) genes located in this region have shown consistent associations. We performed dense genotyping of SNPs in this region to refine the previously reported association signals for lung cancer risk. Two hundred and fifteen SNPs were genotyped on an Illumina iSelect panel, in a hospital-based case-control study of 1681 lung cancer cases and 1235 unaffected controls. Association was tested using unconditional logistic regression, while adjusting for age, sex and pack-years smoked. Furthermore, since many of the SNPs were in linkage disequilibrium (LD), haplotype blocks were constructed, from which tagging SNPs at an r(2) threshold of ≥0.95 were included in a stepwise forward selection logistic regression model. Of the 215 SNPs, 69 were significant at P < 0.05 in univariate analysis; of these, 35 SNPs meeting the r(2) threshold were included in the multiple logistic regression model. Two SNPs, rs370348 (odds ratio = 0.76, P = 1.6 × 10(-6)) and rs4975538 (odds ratio = 1.18, P = 0.005), significantly associated with risk in the overall sample. Among ever smokers, rs4975615 (odds ratio = 0.75, P = 1.2 × 10(-4)) and rs4975538 (odds ratio = 1.26, P = 0.002) were significant, whereas among never-smokers, rs451360 (odds ratio = 0.62, P = 7.6 × 10(-5)) was significant. We refined the consistent association signal in this region, allowing for the considerable LD between SNPs and identified four novel SNPs that were independently and significantly associated with lung cancer risk. Results of these analyses strongly suggest effects on risk from several loci in the TERT/CLPTM1L region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771723      PMCID: PMC3179422          DOI: 10.1093/carcin/bgr136

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  28 in total

1.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

2.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix.

Authors:  J Li; L Ji
Journal:  Heredity (Edinb)       Date:  2005-09       Impact factor: 3.821

3.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

4.  Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.

Authors:  Yufei Wang; Peter Broderick; Athena Matakidou; Timothy Eisen; Richard S Houlston
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

5.  Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.

Authors:  Alison L Van Dyke; Michele L Cote; Angela S Wenzlaff; Judith Abrams; Susan Land; Priyanka Iyer; Ann G Schwartz
Journal:  J Cancer Epidemiol       Date:  2010-02-18

6.  The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia.

Authors:  Chao Agnes Hsiung; Qing Lan; Yun-Chul Hong; Chien-Jen Chen; H Dean Hosgood; I-Shou Chang; Nilanjan Chatterjee; Paul Brennan; Chen Wu; Wei Zheng; Gee-Chen Chang; Tangchun Wu; Jae Yong Park; Chin-Fu Hsiao; Yeul Hong Kim; Hongbing Shen; Adeline Seow; Meredith Yeager; Ying-Huang Tsai; Young Tae Kim; Wong-Ho Chow; Huan Guo; Wen-Chang Wang; Sook Whan Sung; Zhibin Hu; Kuan-Yu Chen; Joo Hyun Kim; Ying Chen; Liming Huang; Kyoung-Mu Lee; Yen-Li Lo; Yu-Tang Gao; Jin Hee Kim; Li Liu; Ming-Shyan Huang; Tae Hoon Jung; Guangfu Jin; Neil Caporaso; Dianke Yu; Chang Ho Kim; Wu-Chou Su; Xiao-Ou Shu; Ping Xu; In-San Kim; Yuh-Min Chen; Hongxia Ma; Min Shen; Sung Ick Cha; Wen Tan; Chin-Hao Chang; Jae Sook Sung; Mingfeng Zhang; Tsung-Ying Yang; Kyong Hwa Park; Jeff Yuenger; Chih-Liang Wang; Jeong-Seon Ryu; Yongbing Xiang; Qifei Deng; Amy Hutchinson; Jun Suk Kim; Qiuyin Cai; Maria Teresa Landi; Chong-Jen Yu; Ju-Yeon Park; Margaret Tucker; Jen-Yu Hung; Chien-Chung Lin; Reury-Perng Perng; Paolo Boffetta; Chih-Yi Chen; Kun-Chieh Chen; Shi-Yi Yang; Chi-Yuan Hu; Chung-Kai Chang; Joseph F Fraumeni; Stephen Chanock; Pan-Chyr Yang; Nathaniel Rothman; Dongxin Lin
Journal:  PLoS Genet       Date:  2010-08-05       Impact factor: 5.917

7.  Lung cancer susceptibility locus at 5p15.33.

Authors:  James D McKay; Rayjean J Hung; Valerie Gaborieau; Paolo Boffetta; Amelie Chabrier; Graham Byrnes; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; John McLaughlin; Frances Shepherd; Alexandre Montpetit; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Lars Vatten; Inger Njølstad; Tomas Axelsson; Chu Chen; Gary Goodman; Matt Barnett; Melissa M Loomis; Jan Lubiñski; Joanna Matyjasik; Marcin Lener; Dorota Oszutowska; John Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; Paolo Vineis; Francoise Clavel-Chapelon; Domenico Palli; Rosario Tumino; Vittorio Krogh; Salvatore Panico; Carlos A González; José Ramón Quirós; Carmen Martínez; Carmen Navarro; Eva Ardanaz; Nerea Larrañaga; Kay Tee Kham; Timothy Key; H Bas Bueno-de-Mesquita; Petra Hm Peeters; Antonia Trichopoulou; Jakob Linseisen; Heiner Boeing; Göran Hallmans; Kim Overvad; Anne Tjønneland; Merethe Kumle; Elio Riboli; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

8.  Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population.

Authors:  Guangfu Jin; Lin Xu; Yongqian Shu; Tian Tian; Jie Liang; Yan Xu; Furu Wang; Jianjian Chen; Juncheng Dai; Zhibin Hu; Hongbing Shen
Journal:  Carcinogenesis       Date:  2009-04-15       Impact factor: 4.944

9.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Authors:  Gloria M Petersen; Laufey Amundadottir; Charles S Fuchs; Peter Kraft; Rachael Z Stolzenberg-Solomon; Kevin B Jacobs; Alan A Arslan; H Bas Bueno-de-Mesquita; Steven Gallinger; Myron Gross; Kathy Helzlsouer; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Harvey A Risch; Wei Zheng; Demetrius Albanes; William R Bamlet; Christine D Berg; Marie-Christine Boutron-Ruault; Julie E Buring; Paige M Bracci; Federico Canzian; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J Duell; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Manal Hassan; Barbara Howard; David J Hunter; Amy Hutchinson; Mazda Jenab; Rudolf Kaaks; Charles Kooperberg; Vittorio Krogh; Robert C Kurtz; Shannon M Lynch; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Hemang Parikh; Alpa V Patel; Petra H M Peeters; Aleksandar Rajkovic; Elio Riboli; Laudina Rodriguez; Daniela Seminara; Xiao-Ou Shu; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Jarmo Virtamo; Jean Wactawski-Wende; Zhaoming Wang; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Joseph F Fraumeni; Robert N Hoover; Patricia Hartge; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-01-24       Impact factor: 38.330

10.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk.

Authors:  Yufei Wang; Peter Broderick; Emily Webb; Xifeng Wu; Jayaram Vijayakrishnan; Athena Matakidou; Mobshra Qureshi; Qiong Dong; Xiangjun Gu; Wei Vivien Chen; Margaret R Spitz; Timothy Eisen; Christopher I Amos; Richard S Houlston
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

View more
  41 in total

1.  Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.

Authors:  Linda Kachuri; Christopher I Amos; James D McKay; Mattias Johansson; Paolo Vineis; H Bas Bueno-de-Mesquita; Marie-Christine Boutron-Ruault; Mikael Johansson; J Ramón Quirós; Sabina Sieri; Ruth C Travis; Elisabete Weiderpass; Loic Le Marchand; Brian E Henderson; Lynne Wilkens; Gary E Goodman; Chu Chen; Jennifer A Doherty; David C Christiani; Yongyue Wei; Li Su; Shelley Tworoger; Xuehong Zhang; Peter Kraft; David Zaridze; John K Field; Michael W Marcus; Michael P A Davies; Russell Hyde; Neil E Caporaso; Maria Teresa Landi; Gianluca Severi; Graham G Giles; Geoffrey Liu; John R McLaughlin; Yafang Li; Xiangjun Xiao; Gord Fehringer; Xuchen Zong; Robert E Denroche; Philip C Zuzarte; John D McPherson; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2015-11-20       Impact factor: 4.944

2.  CLPTM1L polymorphism and lung cancer risk.

Authors:  Min Tang; Xiaonian Bian; Qiuliang Zhao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Quantitative assessment of common genetic variants on chromosome 5p15 and lung cancer risk.

Authors:  Hongyu Wu; Ren Zhu
Journal:  Tumour Biol       Date:  2014-03-12

4.  TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.

Authors:  Wei Nie; Yuansheng Zang; Jiquan Chen; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-02-18

5.  Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies.

Authors:  De-ping Zhao; Chen-lu Yang; Xiao Zhou; Jia-an Ding; Ge-ning Jiang
Journal:  Mol Genet Genomics       Date:  2014-06-07       Impact factor: 3.291

6.  Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls.

Authors:  Xiaozheng Kang; Hongliang Liu; Mark W Onaitis; Zhensheng Liu; Kouros Owzar; Younghun Han; Li Su; Yongyue Wei; Rayjean J Hung; Yonathan Brhane; John McLaughlin; Paul Brennan; Heike Bickeböller; Albert Rosenberger; Richard S Houlston; Neil Caporaso; Maria Teresa Landi; Joachim Heinrich; Angela Risch; Xifeng Wu; Yuanqing Ye; David C Christiani; Christopher I Amos; Qingyi Wei
Journal:  Carcinogenesis       Date:  2016-02-10       Impact factor: 4.944

7.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case-control study in northeast Chinese male population.

Authors:  Yue Zhang; Mengmeng Zhao; Li Shen; Yangwu Ren; Lingyan Su; Xuelian Li; Zhihua Yin; Baosen Zhou
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

Review 8.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

9.  CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis.

Authors:  Michael A James; Haris G Vikis; Everett Tate; Amy L Rymaszewski; Ming You
Journal:  Cancer Res       Date:  2013-12-23       Impact factor: 12.701

Review 10.  Genetic susceptibility to lung cancer--light at the end of the tunnel?

Authors:  Ariela L Marshall; David C Christiani
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.